Request Deal Involvement

GordonMD and EPIQ Capital led a $115m Series B round in SalioGen Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Sidley Austin

legal advisors

Sidley Austin

Morgan Lewis & Bockius

legal advisors

Morgan Lewis & Bockius

LifeSci Partners

pr advisors

LifeSci Partners

or

Principals

FIDELITY MANAGEMENT & RESEARCH COMPANY

bidder

FIDELITY MANAGEMENT & RESEARCH COMPANY

D1 CAPITAL PARTNERS LP

bidder

D1 CAPITAL PARTNERS LP

CYSTIC FIBROSIS FOUNDATION

bidder

CYSTIC FIBROSIS FOUNDATION

EPIQ CAPITAL

bidder

EPIQ CAPITAL

SYMBIOSIS

bidder

SYMBIOSIS

SALIOGEN THERAPEUTICS

target

SALIOGEN THERAPEUTICS

RD FUND

bidder

RD FUND

T. ROWE PRICE GROUP INC

bidder

T. ROWE PRICE GROUP INC

GORDONMD

bidder

GORDONMD

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - GordonMD and EPIQ Capital led a $115m Series B round in SalioGen Therapeutics.